Harmony Biosciences Holdings, Inc. (HRMY) Analyst Forecast

$27.28

north_east
$0.52 (1.94%)
Day's range
$26.72
Day's range
$27.43

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
11/24/2025 Oppenheimer Andreas Argyrides $62.00 $34.31   80.71%
07/10/2025 Goldman Sachs Corinne Johnson $33.00 $34.33   -3.87%
10/30/2024 Goldman Sachs Corinne Jenkins $28.00 $41.49   -32.51%
10/10/2024 Mizuho Securities Graig Suvannavejh $52.00 $33.60   54.76%
09/10/2024 UBS Ashwani Verma $56.00 $36.89   51.8%
08/08/2024 Mizuho Securities Graig Suvannavejh $42.00 $33.55   25.19%
06/24/2024 Oppenheimer Francois Brisebois $56.00 $30.39   84.27%
05/01/2024 Needham Ami Fadia $52.00 $30.37   71.22%
04/30/2024 Raymond James Danielle Brill $37.00 $30.91   19.7%
10/14/2022 Jefferies Chris Howerton $61.00 $47.63   28.07%

Harmony Biosciences Holdings, Inc. FAQ's

Harmony Biosciences Holdings, Inc. has been rated by research analysts at Mizuho Securities, Oppenheimer, UBS, H.C. Wainwright, Goldman Sachs, Needham in the past 90 days.